Inogen, Inc. (INGN) vs NervGen Pharma Corp. Common stock (NGEN)

A side-by-side comparison of Inogen, Inc. and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Inogen, Inc. logo
INGN
Inogen, Inc.
$158M
$5.82HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
NervGen Pharma Corp. Common stock logo
NGEN
NervGen Pharma Corp. Common stock
$148M
$1.80HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT

Total return — INGN vs NGEN

growth of $100 · dividends reinvested · last 1y
INGN -11.6% (-11.6%/yr)NGEN -57.6% (-57.6%/yr)INGN compounded faster over this window
406080100120140Start $1002026$88$42
INGN NGEN

INGN vs NGEN: by the numbers

  • •INGN is the larger company ($158M vs $148M market cap).
  • •Both run net losses; NGEN's is the smaller (0.00% vs -6.94% net margin).

Metrics side by side

Valuation

MetricINGNNGEN
P/S ratio0.44N/A
P/B ratio0.9012.14

Profitability

MetricINGNNGEN
Gross margin48.89%0.00%
Operating margin-8.45%0.00%
Net margin-6.94%0.00%
ROE-14.07%-397.38%
ROIC-13.94%-223.90%

Growth (annualized)

MetricINGNNGEN
Revenue CAGR (5Y)1.02%N/A
Total return CAGR (5Y)-32.83%N/A

Go deeper

Full INGN analysisFull NGEN analysisInteractive comparison tool

Dig into the metrics

Inogen ROENervGen Pharma Corp. Common stock ROEInogen operating marginNervGen Pharma Corp. Common stock operating marginInogen revenue growthNervGen Pharma Corp. Common stock revenue growthInogen free cash flowNervGen Pharma Corp. Common stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.